fbpx

Category: Blog

Dear customers,

ChemDiv appreciates your business and puts customer experience and satisfaction as our priority.

Please take a moment to tell …

Read More

ChemDiv invites you to participate in our customer experience survey.

Our team works hard to provide the best service for you.

Read More

We greatly appreciate your business and put customer experience and satisfaction as our top priority.

Read More

Wishing you a joyous holiday season and a most prosperous and healthy New Year!

ChemDiv’s CADD team can help accelerate the early stages of your drug discovery project.

Read More

Annotated chemical libraries integrate information on biological activities with chemical data.

Read More

Black Friday weekend is just a day away but you can already take advantage of the so much-anticipated shopping event right now.

Read More

We are proud to announce that ChemDiv has developed CHEMVIDIA, an Analytical System with AI elements, based on pubmed data base, which is designed to predict novel trends in small-molecule drug discovery.

Read More

ChemDiv presents a brand new library – Opportunistic Pathogens of Immunocompromised Hosts Annotated Library (OPICH library), which consists of over 2,500 compounds.

Read More

ChemDiv offers you CADD support as a complementary service for your discovery projects.

Read More

ChemDiv presents the new 3D-Pharmacophore Based Diversity Library, Set of small-molecule compounds with high diversity in terms of potential pharmacophore points.

Read More

Preplated compounds libraries from ChemDiv,Inc (10-100ul@10mM per well DMSO solutions frozen. Designed for customers from ACADEMIA)

Read More

X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X